BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

789 related articles for article (PubMed ID: 32269162)

  • 21. Synergistic interactions of sulfamethoxazole and azole antifungal drugs against emerging multidrug-resistant Candida auris.
    Eldesouky HE; Li X; Abutaleb NS; Mohammad H; Seleem MN
    Int J Antimicrob Agents; 2018 Dec; 52(6):754-761. PubMed ID: 30145250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal of Azole Resistance in Candida albicans by Sulfa Antibacterial Drugs.
    Eldesouky HE; Mayhoub A; Hazbun TR; Seleem MN
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
    Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G
    Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of action of novel synthetic dodecapeptides against Candida albicans.
    Maurya IK; Thota CK; Sharma J; Tupe SG; Chaudhary P; Singh MK; Thakur IS; Deshpande M; Prasad R; Chauhan VS
    Biochim Biophys Acta; 2013 Nov; 1830(11):5193-203. PubMed ID: 23876294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species.
    Nagayoshi Y; Miyazaki T; Shimamura S; Nakayama H; Minematsu A; Yamauchi S; Takazono T; Nakamura S; Yanagihara K; Kohno S; Mukae H; Izumikawa K
    PLoS One; 2017; 12(7):e0180990. PubMed ID: 28700656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Azole resistance in Candida auris: mechanisms and combinatorial therapy.
    Jangir P; Kalra S; Tanwar S; Bari VK
    APMIS; 2023 Aug; 131(8):442-462. PubMed ID: 37337929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterologous Expression of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provides Tools for Antifungal Discovery.
    Keniya MV; Ruma YN; Tyndall JDA; Monk BC
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fungicidal Potency and Mechanisms of θ-Defensins against Multidrug-Resistant Candida Species.
    Basso V; Garcia A; Tran DQ; Schaal JB; Tran P; Ngole D; Aqeel Y; Tongaonkar P; Ouellette AJ; Selsted ME
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mathematical Modeling of Fluconazole Resistance in the Ergosterol Pathway of
    Yu PK; Moron-Espiritu LS; Lao AR
    mSystems; 2022 Dec; 7(6):e0069122. PubMed ID: 36383015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of Novel Schiff base Derivatives as Antifungal Compounds in Combination with Approved Drugs Against Candida Albicans.
    Malik MA; Lone SA; Gull P; Dar OA; Wani MY; Ahmad A; Hashmi AA
    Med Chem; 2019; 15(6):648-658. PubMed ID: 30501599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Transcriptomics Approach To Unveiling the Mechanisms of
    Cavalheiro M; Costa C; Silva-Dias A; Miranda IM; Wang C; Pais P; Pinto SN; Mil-Homens D; Sato-Okamoto M; Takahashi-Nakaguchi A; Silva RM; Mira NP; Fialho AM; Chibana H; Rodrigues AG; Butler G; Teixeira MC
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30348666
    [No Abstract]   [Full Text] [Related]  

  • 32. Divergent mitochondrial responses and metabolic signal pathways secure the azole resistance in Crabtree-positive and negative
    Zhou M; Peng J; Ren K; Yu Y; Li D; She X; Liu W
    Microbiol Spectr; 2024 Apr; 12(4):e0404223. PubMed ID: 38442003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclic AMP signaling pathway modulates susceptibility of candida species and Saccharomyces cerevisiae to antifungal azoles and other sterol biosynthesis inhibitors.
    Jain P; Akula I; Edlind T
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3195-201. PubMed ID: 14506030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a selective, iron-chelating antifungal compound that disrupts fungal metabolism and synergizes with fluconazole.
    Corrales J; Ramos-Alonso L; González-Sabín J; Ríos-Lombardía N; Trevijano-Contador N; Engen Berg H; Sved Skottvoll F; Moris F; Zaragoza O; Chymkowitch P; Garcia I; Enserink JM
    Microbiol Spectr; 2024 Feb; 12(2):e0259423. PubMed ID: 38230926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic effects of ketamine and azole derivatives on
    de Andrade Neto JB; da Silva CR; Barroso FD; do Amaral Valente Sá LG; de Sousa Campos R; S Aires do Nascimento FB; Sampaio LS; da Silva AR; da Silva LJ; de Sá Carneiro I; Queiroz HA; de Mesquita JRL; Cavalcanti BC; de Moraes MO; Nobre Júnior HV
    Future Microbiol; 2020 Feb; 15():177-188. PubMed ID: 32077323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluconazole analogues with metal-binding motifs impact metal-dependent processes and demonstrate antifungal activity in Candida albicans.
    Hunsaker EW; McAuliffe KJ; Franz KJ
    J Biol Inorg Chem; 2020 Aug; 25(5):729-745. PubMed ID: 32542530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthetic antimicrobial β-peptide in dual-treatment with fluconazole or ketoconazole enhances the in vitro inhibition of planktonic and biofilm Candida albicans.
    Mora-Navarro C; Caraballo-León J; Torres-Lugo M; Ortiz-Bermúdez P
    J Pept Sci; 2015 Dec; 21(12):853-61. PubMed ID: 26470850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic and drug-resistant reversing effects of diorcinol D combined with fluconazole against Candida albicans.
    Li Y; Chang W; Zhang M; Li X; Jiao Y; Lou H
    FEMS Yeast Res; 2015 Mar; 15(2):. PubMed ID: 25752309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Species-Specific Differences in C-5 Sterol Desaturase Function Influence the Outcome of Azole Antifungal Exposure.
    Luna-Tapia A; Parker JE; Kelly SL; Palmer GE
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0104421. PubMed ID: 34516249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Vitro Activities of Novel Azole Compounds ATTAF-1 and ATTAF-2 against Fluconazole-Susceptible and -Resistant Isolates of Candida Species.
    Fakhim H; Emami S; Vaezi A; Hashemi SM; Faeli L; Diba K; Dannaoui E; Badali H
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.